Your session is about to expire
← Back to Search
Observational for Squamous Cell Carcinoma
N/A
Recruiting
Led By Kathryn M. Van Abel, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights
Study Summary
The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is absent.
Eligible Conditions
- Squamous Cell Carcinoma
- Oropharyngeal Cancer
- Oropharyngeal Carcinoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in biomarkers
Genetic alterations
Immunologic biomarkers for predicting progression free survival
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo blood sample collection, saliva sample collection, complete questionnaires and have their medical records reviewed on study.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,221 Previous Clinical Trials
3,768,960 Total Patients Enrolled
Kathryn M. Van Abel, M.D.Principal InvestigatorMayo Clinic in Rochester
1 Previous Clinical Trials
154 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger